Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats
Emanuela Mhillaj, Maria Grazia Morgese, Paolo Tucci, et al.
Neuroscience (2018) Vol. 372, pp. 58-73
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
Rishika Dhapola, Subhendu Shekhar Hota, Phulen Sarma, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 6, pp. 1669-1681
Open Access | Times Cited: 227
Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use
Anna Skrzypczak-Wiercioch, Kinga Sałat
Molecules (2022) Vol. 27, Iss. 17, pp. 5481-5481
Open Access | Times Cited: 139
Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
Awanish Mishra, Ritam Bandopadhyay, Prabhakar Singh, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1591-1626
Closed Access | Times Cited: 98
Improvement of astrocytic gap junction involves the anti-depressive effect of celecoxib through inhibition of NF-κB
Xiao-xi Zheng, Chengfeng Zhang, Liqing Li, et al.
Brain Research Bulletin (2024) Vol. 207, pp. 110871-110871
Open Access | Times Cited: 8
Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint?
Maria Grazia Morgese, Luigia Trabace
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 60
Is cyclooxygenase‐1 involved in neuroinflammation?
Nafiseh Ghazanfari, Aren van Waarde, Rudi Dierckx, et al.
Journal of Neuroscience Research (2021) Vol. 99, Iss. 11, pp. 2976-2998
Open Access | Times Cited: 40
Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease
Valentina Vellecco, Anella Saviano, Federica Raucci, et al.
Pharmacological Research (2022) Vol. 187, pp. 106595-106595
Open Access | Times Cited: 22
Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease
Barbara E. Stopschinski, Rick Weideman, Danni McMahan, et al.
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 15
rTMS ameliorates CUMS-induced anxiety-depression-like behaviour and cognitive dysfunction in rats by modulating the COX-2/PGE2 signalling pathway
Yanjiao Pei, Huanhuan Liu, Jiqing Lang, et al.
Journal of Psychiatric Research (2025)
Closed Access
Fucosterol from an Edible Brown Alga Ecklonia stolonifera Prevents Soluble Amyloid Beta-Induced Cognitive Dysfunction in Aging Rats
Jeong Hwan Oh, Jae Sue Choi, Taek‐Jeong Nam
Marine Drugs (2018) Vol. 16, Iss. 10, pp. 368-368
Open Access | Times Cited: 46
COX-2-PGE2 signaling pathway contributes to hippocampal neuronal injury and cognitive impairment in PTZ-kindled epilepsy mice
Xinjian Zhu, Yuanyuan Yao, Jiurong Yang, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106801-106801
Closed Access | Times Cited: 34
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation
Bruno Dutra Arbo, Lúcia Emanueli Schimith, Michele Goulart dos Santos, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174800-174800
Open Access | Times Cited: 19
Sulforaphane Alleviates Lipopolysaccharide-induced Spatial Learning and Memory Dysfunction in Mice: The Role of BDNF-mTOR Signaling Pathway
Jie Gao, Bingrui Xiong, Bo Zhang, et al.
Neuroscience (2018) Vol. 388, pp. 357-366
Closed Access | Times Cited: 36
Hashimoto’s thyroiditis induces neuroinflammation and emotional alterations in euthyroid mice
Yaojun Cai, Fen Wang, Zhang-Xiang Chen, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 35
Opposing effects of IL-1β/COX-2/PGE2 pathway loop on islets in type 2 diabetes mellitus
Guanqiao Wang, Rui Liang, Tengli Liu, et al.
Endocrine Journal (2019) Vol. 66, Iss. 8, pp. 691-699
Open Access | Times Cited: 32
Involvement of endoplasmic reticulum stress in amyloid β (1-42)-induced Alzheimer’s like neuropathological process in rat brain
Poonam Goswami, Mohd Amir Afjal, Juheb Akhter, et al.
Brain Research Bulletin (2020) Vol. 165, pp. 108-117
Closed Access | Times Cited: 28
Environmental Toxins and Alzheimer’s Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation
Rishika Dhapola, Prajjwal Sharma, Sneha Kumari, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3657-3677
Closed Access | Times Cited: 10
Cyclooxygenase-2 inhibitors alleviated depressive and anxious-like behaviors in mice exposed to lipopolysaccharide: Involvement of oxidative stress and neuroinflammation
Daniel Moreira Alves da Silva, Iardja Stéfane Lopes Sales, João Victor Souza Oliveira, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 240, pp. 173778-173778
Closed Access | Times Cited: 3
Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study
Farnoosh Usefi, Auob Rustamzadeh, Zahra Ghobadi, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 6, pp. 1201-1211
Closed Access | Times Cited: 3
Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
A. Tolédano, Arantxa Rodríguez‐Casado, María‐Isabel Álvarez, et al.
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1101-1101
Open Access | Times Cited: 3
Steroid-Enriched Fraction of Achyranthes bidentata Protects Amyloid β Peptide 1–40-Induced Cognitive Dysfunction and Neuroinflammation in Rats
Liwei Lin, Fan-Hsuan Tsai, Wan-Cheng Lan, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5671-5688
Closed Access | Times Cited: 27
Depressive-like phenotype evoked by lifelong nutritional omega-3 deficiency in female rats: Crosstalk among kynurenine, Toll-like receptors and amyloid beta oligomers
Maria Grazia Morgese, Stefania Schiavone, Angela Bruna Maffione, et al.
Brain Behavior and Immunity (2020) Vol. 87, pp. 444-454
Closed Access | Times Cited: 24
Alterations and interactions of subcortical modulatory systems in Alzheimer's disease
Mirjana Babić Leko, Patrick R. Hof, Goran Šimić
Progress in brain research (2021), pp. 379-421
Closed Access | Times Cited: 22
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play
Rosmara Infantino, Serena Boccella, Damiana Scuteri, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113844-113844
Open Access | Times Cited: 14
Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats
Vladimirs Piļipenko, Karīna Narbute, Jolanta Pupure, et al.
Neuropharmacology (2018) Vol. 144, pp. 319-326
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top